Effect of microwaves platform on reduction of abdominal subcutaneous fat

Effect of microwaves platform on reduction of abdominal subcutaneous fat and plasma leptin and adiponectin level.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181010041303N1

Enrollment

Registered

2020-11-15

Start date

2020-10-27

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overweight. Overweight

Interventions

Intervention group:According to the standard treatment protocol, patients are treated with microwave technology (2.5 GHz radiofrequency) using Onda device (Onda, DEKA technology, Florence, Italy) for

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Healthy people aged 18 to 65 years overweight with a body mass index (BMI) of less than 30 kg / m2 Intra-abdominal fat volume less than 12 kg Absence of active cancer (chemotherapy / radiotherapy) in the last 6 months No non-invasive lipolysis in the abdomen or other parts of the body in the last 3 months completing a moral consent or no legal prohibition on intervention Absence of abdominal surgery in the last 6 months Absence of acute heart disease in the last 6 months Absence of liver cirrhosis in the last 6 months

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Use of anticoagulants (other than aspirin) Use of isotretinoin drugs Secretion skin lesions and active eczema on the surface of the abdominal skin

Design outcomes

Primary

Measure	Time frame
Body mass index: ratio of weight (kg) to height2 (m2). Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: Using the formula weight (kg)/ height 2 (m2).;Percentage of body fat. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: with body analyzer.;Waist circumference. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: Using a tape measure.;The thickness of the subcutaneous fat tissue of the abdomen. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By ultrasound device.;Intra-abdominal adipose tissue volume. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By ultrasound device.;Serum levels of adiponectin. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.;Serum levels of lipoprotein lipase. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.;Prooxidane-Antioxidant Balance (PAB). Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By calorimetric method.;Serum levels of leptin. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.	—

Measure

Time frame

Body mass index: ratio of weight (kg) to height2 (m2). Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: Using the formula weight (kg)/ height 2 (m2).;Percentage of body fat. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: with body analyzer.;Waist circumference. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: Using a tape measure.;The thickness of the subcutaneous fat tissue of the abdomen. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By ultrasound device.;Intra-abdominal adipose tissue volume. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By ultrasound device.;Serum levels of adiponectin. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.;Serum levels of lipoprotein lipase. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.;Prooxidane-Antioxidant Balance (PAB). Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: By calorimetric method.;Serum levels of leptin. Timepoint: At the beginning of the study (before the intervention) and 20, 40 and 60 days after the start. Method of measurement: ELISA kit.

—

Secondary

Measure	Time frame
Daily calorie intake. Timepoint: baseline. Method of measurement: food frequency questionnaire.;Daily physical activity. Timepoint: baseline. Method of measurement: IPAQ questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdolreza Norouzy

Mashhad University of Medical Sciences

norouzya@mums.ac.ir+98 51 3882 7034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026